
| 2-Deoxy-D-glucose,154-17-6 | ||||||
| Cat.No.:IC-0126415 | ||||||
| Product Information | ||||||
| Biological Activity | ||||||
| 2-Deoxy-D-glucose (2DG), is a glucose analogue, act as competitive glycolytic inhibitor [1].2-Deoxy-d-glucose (2DG) has been demonstrated to be a powerful agent for blocking and probing increased sugar metabolism in cancer cells [2]. Because of its similarity to glucose, 2-Deoxy-D-glucose inhibits glycolysis, but as chemically it is also 2-deoxymannose it is able to compete with mannose in the growing lipid-linked oligosaccharide chain during the initial steps of N-linked glycosylation. This mannose-like property of 2-Deoxy-D-glucose results in misfolded proteins leading to endoplasmic reticulum (ER) stress [3].2-Deoxy-D-glucose delivered in the diet produces cardiac toxicity in rats at doses ranging from 0.02 to 0.3 g/kg (0.04-0.6% 2-Deoxy-D-glucose by weight in the diet) and hastens mortality at doses above 0.2 g/kg (0.4% in the diet) [4]. 2-Deoxy-D-glucose evoked increases in plasma adrenaline and glucose at 20 and 60 min [5]. | ||||||
| Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines) | ||||||
| Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog | 
| Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 | 
| Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 | 
| Km factor | 3 | 6 | 12 | 8 | 5 | 20 | 
| 
					Animal A (mg/kg) = Animal B (mg/kg) multiplied by  (Animal B Km / Animal A Km) | ||||||
| Order Information | ||||||
| 
					 | Quantity | Price($) | Price(€) | Availability | ||
| 1g | $75.00 | €90.00 | In stock | |||
| 5g | $223.00 | €267.60 | In stock | |||
| 10g | $383.00 | €459.60 | In stock | |||
| Free Delivery on orders over $350.00. | ||||||
| Chemical Information | ||||||
| Molecular Weight | 164.16 | |||||
| Formula | C6H12O5 | |||||
| CAS Number | 154-17-6 | |||||
| Purity | >98.00% | |||||
| Solubility | DMF: 10 mg/ml,DMSO: 20 mg/ml,PBS (pH 7.2): 10 mg/ml | |||||
| Storage | -20¡æ | |||||
| Reference | ||||||
| [1]. M¨¹hlenberg T, Grunewald S, Treckmann J, et al. Inhibition of KIT-glycosylation by 2-deoxyglucose abrogates KIT-signaling and combination with ABT-263 synergistically induces apoptosis in gastrointestinal stromal tumor[J]. PloS one, 2015, 10(3): e0120531. | ||||||
| [2]. El Mjiyad N, Caro-Maldonado A, Ramirez-Peinado S, Munoz-Pinedo C. Sugar-free approaches to cancer cell killing. Oncogene. 2011 Jan;30(3):253-64. | ||||||
| [3]. Kurtoglu, Metin, Johnathan C. Maher, and Theodore J. Lampidis. "Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells." Antioxidants & redox signaling 9.9 (2007): 1383-1390. | ||||||
| [4]. Minor R K, Smith Jr D L, Sossong A M, et al. Chronic ingestion of 2-deoxy-D-glucose induces cardiac vacuolization and increases mortality in rats[J]. Toxicology and applied pharmacology, 2010, 243(3): 332-339. | ||||||
| [5]. Bobrovskaya L, Damanhuri H A, Ong L K, et al. Signal transduction pathways and tyrosine hydroxylase regulation in the adrenal medulla following glucoprivation: an in vivo analysis[J]. Neurochemistry international, 2010, 57(2): 162-167. | ||||||
| We Devoted Ourselves To The Development Of Biomedical Research Reagent. | ||||||









